Design, synthesis, evaluation and molecular modeling study of 4-N-phenylaminoquinolines for Alzheimer disease treatment
作者:Jun Zhu、Li-Ning Wang、Rong Cai、Shang-Qi Geng、Ya-Fei Dong、Yu-Ming Liu
DOI:10.1016/j.bmcl.2019.03.050
日期:2019.6
to positively modify the disease's course. In this work, a new series of 4-N-phenylaminoquinolines was synthesized and evaluated for their abilities to inhibit AChE and BChE. Compound 11b showed significant inhibitory activities on AChE and BChE with IC50 values of 0.86 and 2.65 μM, respectively, a lot better than that of reference drug galanthamine. Furthermore, docking study showed that compound 11b
双结合位点乙酰胆碱酯酶(AChE)抑制剂和丁酰胆碱酯酶(BChE)抑制剂最近作为两类新型抗阿尔茨海默病药物出现,以积极改变疾病进程。在这项工作中,合成了一系列新的4-N-苯基氨基喹啉并评估了它们抑制AChE和BChE的能力。化合物11b对AChE和BChE表现出明显的抑制活性,IC50值分别为0.86和2.65μM,比参考药物加兰他敏好得多。此外,对接研究表明化合物11b不仅与AChE的活性位点和周围位点同时相互作用,而且还与BChE活性位点的所有五个区域相互作用。这些发现表明,这些衍生物可以被视为进一步药物开发的有希望的起点。